@article{e5195e76dd6c4e299f490f39f333001b,
title = "A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registry",
keywords = "Advanced breast cancer, Metastatic breast cancer, Everolimus, Hormone-receptor-positive, Real life, Progression-free survival, AROMATASE INHIBITORS, TRIAL, CHEMOTHERAPY, MULTICENTER, EFFICACY, THERAPY, SAFETY",
author = "Knapen, {L. M.} and Geurts, {S. M. E.} and Ibragimova, {K. I. E.} and S. Croes and Vriens, {B. E. P. J.} and {van den Berkmortel}, {F. W. P. J.} and Dercksen, {M. W.} and {van de Wouw}, {A. J.} and Pepels, {M. J. A. E.} and {de Fallois}, {A. O. J.} and Lobbezoo, {D. J. A.} and {de Boer}, M. and Tjan-Heijnen, {V. C. G.}",
year = "2019",
month = apr,
doi = "10.1016/j.breast.2019.01.001",
language = "English",
volume = "44",
pages = "46--51",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",
}